Mortimer et al., 1964 - Google Patents
The role of the upper gastrointestinal flora in the malabsorption syndromeMortimer et al., 1964
View PDF- Document ID
- 15124540247229130321
- Author
- Mortimer D
- Reed P
- Vidinli M
- Finlay J
- Publication year
- Publication venue
- Canadian Medical Association Journal
External Links
Snippet
Bacterial contamination of the upper gastrointestinal tract by colonic flora appears important in the production of some forms of secondary steatorrhea. Gastric contents have been studied in patients with normal intestinal absorption and with malabsorption syndrome. In …
- 230000002496 gastric 0 title abstract description 76
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7018629B2 (en) | Probiotic compositions for the treatment of inflammatory bowel disease | |
| Guarino et al. | Oral immunoglobulins for treatment of acute rotaviral gastroenteritis | |
| Poth | Intestinal antisepsis in surgery | |
| RU2468808C2 (en) | Method of treating or preventing systemic inflammation | |
| Giannella et al. | Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro | |
| KR20170084317A (en) | Oral rehydration composition and methods thereof | |
| US5550106A (en) | Low buffer nutritional composition | |
| Mortimer et al. | The role of the upper gastrointestinal flora in the malabsorption syndrome | |
| Sumi et al. | On the pathogenesis of diabetic steatorrhea | |
| CN116966264A (en) | Wheat peptide composition with synergistic constipation relieving effect and application thereof | |
| Rider et al. | Use of silicone in the treatment of intestinal gas and bloating | |
| EP0401056B1 (en) | Glutamine in the treatment of impaired host defences | |
| Penna et al. | Up-to-date clinical and experimental basis for the use of probiotics | |
| Schmidt et al. | Infant botulism: a case series and review of the literature | |
| Kakinuma et al. | The first case of type B infant botulism in Japan | |
| RU2123345C1 (en) | Agent for disbacteriosis treatment | |
| US3992521A (en) | Immunological product for the treatment of intestinal infections due to pathogenic enterobacteria of the infant | |
| Wirts et al. | The correction of postgastrectomy malabsorption following a jejunal interposition operation | |
| JPS6277322A (en) | Aging preventing agent | |
| RU2746642C1 (en) | Method for complex sequential use of pathogenetic agents in treatment in children with tuberculosis infection | |
| RU2012341C1 (en) | Method of treating neonates suffering from sepsis | |
| Jonxis et al. | The treatment of ascaris infection with velardon | |
| RU2234932C2 (en) | Method for treatment of cows with eumeriosis | |
| Wadhwa et al. | Anorexia management in dogs | |
| Necheles et al. | Medical treatment of cardiospasm |